AU2001233543A1 - Carrier particles for drug delivery and process for preparation - Google Patents

Carrier particles for drug delivery and process for preparation

Info

Publication number
AU2001233543A1
AU2001233543A1 AU2001233543A AU3354301A AU2001233543A1 AU 2001233543 A1 AU2001233543 A1 AU 2001233543A1 AU 2001233543 A AU2001233543 A AU 2001233543A AU 3354301 A AU3354301 A AU 3354301A AU 2001233543 A1 AU2001233543 A1 AU 2001233543A1
Authority
AU
Australia
Prior art keywords
preparation
drug delivery
carrier particles
particles
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233543A
Other languages
English (en)
Inventor
Daniel L. Sparks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ottawa Heart Institute Research Corp
Original Assignee
Ottawa Heart Institute Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ottawa Heart Institute Research Corp filed Critical Ottawa Heart Institute Research Corp
Publication of AU2001233543A1 publication Critical patent/AU2001233543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001233543A 2000-02-14 2001-02-14 Carrier particles for drug delivery and process for preparation Abandoned AU2001233543A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09503187 2000-02-14
US09/503,187 US6514523B1 (en) 2000-02-14 2000-02-14 Carrier particles for drug delivery and process for preparation
PCT/CA2001/000175 WO2001058492A2 (fr) 2000-02-14 2001-02-14 Particules porteuses pour administration de substances medicamenteuses, et leur procede de preparation

Publications (1)

Publication Number Publication Date
AU2001233543A1 true AU2001233543A1 (en) 2001-08-20

Family

ID=24001073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233543A Abandoned AU2001233543A1 (en) 2000-02-14 2001-02-14 Carrier particles for drug delivery and process for preparation

Country Status (5)

Country Link
US (1) US6514523B1 (fr)
EP (1) EP1257294A2 (fr)
AU (1) AU2001233543A1 (fr)
CA (1) CA2437289A1 (fr)
WO (1) WO2001058492A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8568766B2 (en) * 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
CA2486127C (fr) 2002-05-17 2014-03-11 Esperion Therapeutics, Inc. Methode de traitement de troubles dyslipidemiques
WO2004010939A2 (fr) * 2002-07-30 2004-02-05 Esperion Therapeutics, Inc. Procedes d'utilisation de la proteine animale non humaine apolipoproteine a-i
AU2003290825C1 (en) * 2002-11-13 2009-12-10 The Uab Research Foundation Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use
TW201424770A (zh) * 2003-02-14 2014-07-01 Childrens Hosp & Res Ct Oak 親脂藥物傳送媒介物及其使用方法
EP1599598A4 (fr) 2003-03-04 2007-08-08 Yeda Res & Dev Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
US20040253293A1 (en) * 2003-06-16 2004-12-16 Afshin Shafiee Rate controlled release of a pharmaceutical agent in a biodegradable device
EP1677763A1 (fr) * 2003-10-01 2006-07-12 Children's Hospital & Research Center at Oakland Vehicule d'administration de medicament lipophile et methodes d'utilisation de ce vehicule
US7348802B2 (en) * 2004-06-15 2008-03-25 Stmicroelectronics Pvt. Ltd. Differential receiver
US20060134174A1 (en) * 2004-12-22 2006-06-22 Bausch & Lomb Incorporated Pharmaceutical delivery system and method of use
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US8932829B2 (en) * 2005-07-07 2015-01-13 Elena Dudich Recombinant alpha-fetoprotein and compositions thereof
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
JP2010538005A (ja) * 2007-08-28 2010-12-09 ユーエービー リサーチ ファウンデーション 合成アポリポ蛋白質ｅ模倣ポリペプチドおよび使用方法
US8557767B2 (en) 2007-08-28 2013-10-15 Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
US8268796B2 (en) 2008-06-27 2012-09-18 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use thereof
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
US10525152B2 (en) 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
KR101132626B1 (ko) 2009-10-12 2012-04-02 주식회사 녹십자 난용성 약물의 전달을 위한 고밀도지단백 나노입자의 제조방법
WO2012135046A1 (fr) * 2011-03-25 2012-10-04 The Trustees Of Columbia University In The City Of New York Particule pégylée d'hdl humaine et procédé pour la production de celle-ci
CN102178954B (zh) * 2011-04-25 2014-05-28 中国药科大学 具有血管壁靶向和逆向转运胆固醇功能的重组高密度脂蛋白载药系统及其应用
CN102846551A (zh) * 2011-06-28 2013-01-02 复旦大学 一种肝靶向高密度脂蛋白类似物纳米粒及其制备方法和用途
CN102614515A (zh) * 2012-04-16 2012-08-01 中国药科大学 具有靶向及双重抗肿瘤作用的新型化学重组高密度脂蛋白载药系统及应用
BR112017001860A2 (pt) 2014-07-31 2018-02-27 Uab Research Foundation peptídeo sintético, composição farmacêutica, métodos, regime de dosagem, e, anticorpo monoclonal
WO2016154542A2 (fr) * 2015-03-25 2016-09-29 The Regents Of The University Of Michigan Compositions et méthodes de traitement d'affections cardiovasculaires
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
US20200138727A1 (en) * 2017-04-21 2020-05-07 University Of North Texas Health Science Center Enhanced therapeutic agent and nucleic acid delivery via hdl or reconstituted hdl nanoparticles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319861C2 (de) 1983-06-01 1986-11-20 Arthur Pfeiffer Vakuumtechnik Wetzlar Gmbh, 6334 Asslar Gasmengendurchfluß-Meßgerät
SE456136B (sv) 1985-06-17 1988-09-12 Oncholab Ab Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
US5128318A (en) 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
FR2664500B1 (fr) 1990-07-13 1994-10-28 Lille Ii Universite Droit Sant Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.
US5149801A (en) 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
SE9702776D0 (sv) * 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
US6287590B1 (en) 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization

Also Published As

Publication number Publication date
WO2001058492A2 (fr) 2001-08-16
EP1257294A2 (fr) 2002-11-20
WO2001058492A3 (fr) 2002-01-31
CA2437289A1 (fr) 2001-08-16
US6514523B1 (en) 2003-02-04

Similar Documents

Publication Publication Date Title
AU2001233543A1 (en) Carrier particles for drug delivery and process for preparation
AU2001235009A1 (en) Drug delivery apparatus
AU5711501A (en) Improved water-insoluble drug particle process
AU3403201A (en) Drug delivery device and method
HUP0101512A3 (en) Adhesive microsphere drug delivery composition, process for its preparation and device containing it
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2002234184A1 (en) Packaging and delivery system for bone graft particles
AU3287699A (en) Ultrasound-mediated drug delivery
AU2002341959A1 (en) Drug delivery devices and methods
AU1719800A (en) Drug delivery systems and methods
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
AU2002326494A1 (en) Products and drug delivery vehicles
AU2002211018A1 (en) Cellulosic particle for pharmaceutical preparation
AU4947100A (en) Drug delivery device
HUP0104687A3 (en) Methods for preparing coated drug particles and pharmaceutical formulations thereof
AU2001250027A1 (en) Apparatus for transport and delivery of articles
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
AU2001276831A1 (en) Delivery vehicle composition and methods for delivering antigens and other drugs
AU2001278622A1 (en) Amorphous carrier materials for drug delivery
AU2001270963A1 (en) Transdermal drug delivery system
AU4312101A (en) Secure delivery receptacle and method for using the same
AU3926000A (en) Methods and compositions for drug delivery
HUP0201629A3 (en) Pharmaceutical complex containing eletriptan and cyclodextrin-derivative, pharmaceutical composition containing it, process for its preparation and its use